COVID-19 has increased the demand for new, safer curbside conveniences and the health care industry—including the pharmacy—has transformed rapidly to meet patient needs and prioritize safety as a result of the pandemic.
Drs Anthony Perissinotti and Kirollos Hanna provide some important considerations for pharmacists in treating chronic lymphocytic leukemia.
The disease is complex, but many opportunities exist for pharmacist intervention.
As pharmacy practice continues to evolve, it is imperative to recognize the vital contributions of all members of the pharmacy team, including pharmacy technicians.
As more becomes known about Crohn disease, treatment modalities have evolved with biologic monoclonal antibodies becoming a key part of guideline- and evidence-based medicine.
Person-centered care focuses on tailoring treatment plans, providing medication support, and ensuring access to resources that meet their unique needs.
For the management of ovarian cancer, it has been observed in both cellular and animal models that curcumin suppresses cell proliferation and promotes apoptosis.
Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Integrating immunotherapies will continue to improve patient outcomes and quality of life.
Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.
Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
Analyzing the patent and trademark challenges faced by 503A compounding pharmacies.
Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.
Precision oncology represents an evolution in therapeutic practice.
From countless hours of studying to participating in pharmacy organizations to volunteering in the community, it’s no surprise that student pharmacists often struggle to find balance as a well-rounded student.
Prevention, role of advanced machine learning systems, safety should be top of mind for next 12 months and beyond
To develop the next generation of pharmacy leaders, pharmacists should receive effective training from the beginning of their careers.
The ability—or lack thereof—to procure drugs can drive prices up and decrease patient accessibility.
Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Meta-analysis of randomized controlled trials adds to growing evidence around certain antihypertensive drug classes showing promise for primary or secondary prevention of diabetes.
Five crucial steps pharmacies can take to enhance patient engagement and lower operational costs.
Real-world data can help resolve access barriers by providing a highly detailed view into the barriers that impact specific patient populations.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Perhaps ashwagandha may aid in stress management, athletic performance, and sleep, but this effect is far from definitive.
Study shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.
Best practices call for referring to resources, such as those from HHS and the University of Liverpool.
Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.
Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.
Pharmacists and student pharmacists became the center of responding to the Monkeypox outbreak by providing immunizations to their communities.